Overall classification | Metastatic patients (n = 82) | Non-metastatic patients (n = 82) | ||
---|---|---|---|---|
Odds ratio a | P a | Odds ratio a | P a | |
Age (≤50 versus >50 years) | 1.004 | 0.97 | 0.914 | 0.57 |
Tumor size (range 6 mm to 50 mm) | 1.002 | 0.56 | 0.990 | 0.19 |
Grade (range 1 to 3) | 1.057 | 0.33 | 0.971 | 0.75 |
ER status (negative versus positive) | 1.002 | 0.98 | 1.095 | 0.56 |
Time to metastasis (range 0 to 181 months) | 1.001 | 0.41 | - | - |
ER-positive classification | Metastatic patients (n = 55) | Non-metastatic patients (n = 55) | ||
Odds ratio a | P a | Odds ratio a | P a | |
Age (≤50 versus >50 years) | 1.088 | 0.49 | 0.526 | 0.053 |
Tumor size (range 6 mm to 50 mm) | 0.996 | 0.34 | 0.991 | 0.36 |
Grade (range 1 to 3) | 1.084 | 0.21 | 1.051 | 0.65 |
Time to metastasis (range 5 to 131 months) | 1.000 | 0.86 | - | - |